Rukobia 600 mg, Retardtabletten

7680678540010 CH-67854 Tabletten
Rukobia 600 mg, Retardtabletten
Rukobia 600 mg, Retardtabletten
Rukobia 600 mg, Retardtabletten
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Summary of Product Characteristics
Allemand
27/06/2025
Summary of Product Characteristics
Français
27/06/2025
Summary of Product Characteristics
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
fostemsavirum
600.0 MG Substance Wirkstoff (Principe actif)
fostemsavirum trometamolum
- Substance WIZUS
hydroxypropylcellulosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
E 171
- Substance FNIDK
macrogolum 3350
- Substance HNIDK
talcum
- Substance HNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK

Authorization holder

ViiV Healthcare GmbH

6340 Baar

Authorization information

Swissmedic authorization number
67854
Drug name
Rukobia, Retardtabletten
Galenic form
RETT
ATC Code
J05AX29
Authorization status
Z
Dispensing category
A
First authorization
28/09/2021
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektion

Package details

Description (FR)
RUKOBIA cpr pell ret 600 mg fl 60 pce
Description (DE)
RUKOBIA Ret Filmtabl 600 mg Fl 60 Stk
Market launch
28/09/2021
Narcotic (BTM)
No
Buy us a coffee Explore the data